Related Experiment Video
Updated: Jul 19, 2026
08:46
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
Vaccination against malaria with live parasites
Laurent Rénia1, Anne Charlotte Grüner, Marjorie Mauduit
1Institut Cochin, Département d'Immunologie, Hôpital Cochin, 27 rue du Fg Saint Jacques, 75014 Paris, France. renia@cochin.inserm.fr
Expert Review of Vaccines
|September 23, 2006
Summary
Despite decades of research, malaria vaccines remain elusive. Live, attenuated parasites offer a promising avenue for inducing immunity, though challenges remain for widespread use.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Malaria persists as a major global infectious disease despite extensive research and control efforts.
- Natural immunity develops in endemic populations, suggesting vaccine development is feasible.
- Whole parasite vaccination with attenuated strains induces sterile immunity in humans.
Purpose of the Study:
- To review historical vaccine studies and recent advancements in malaria vaccine research.
- To discuss the potential and challenges of using live, attenuated parasites for malaria vaccination.
- To explore the renewed interest in live parasite vaccines due to subunit vaccine limitations.
Main Methods:
- Review of past vaccination trials and studies on malaria parasites.
- Summary of recent developments in genetically modified Plasmodium parasites for vaccination.
- Discussion of challenges hindering mass immunization with live parasites.
Main Results:
- Current subunit malaria vaccines have not consistently achieved complete protection.
- Attenuated whole parasite immunization is the only protocol shown to induce sterile immunity in humans.
- Genetically modified Plasmodium parasites have revitalized interest in live parasite vaccination strategies.
Conclusions:
- Live, attenuated parasites represent a promising strategy for malaria vaccine development.
- Overcoming challenges is crucial for the potential mass immunization with live malaria parasites.
- Further research into live parasite vaccines is warranted given the limitations of current approaches.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...